Effect of Canagliflozin on the Incidence of Atrial Fibrillation in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis
Diabetes Obes Metab 2022 Oct 01;24(10)1927-1938, C Li, J Yu, C Hockham, V Perkovic, BL Neuen, SV Badve, L Houston, VYJ Lee, JY Barraclough, RA Fletcher, KW Mahaffey, HJL Heerspink, CP Cannon, B Neal, C ArnottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.